Telehealth Companies Applaud DEA for Delaying Telemedicine Restrictions of Controlled Substances
After the Drug Enforcement Administration (DEA) announced Wednesday that it is temporarily extending Covid-19 flexibilities for the prescribing of controlled substances via telemedicine, several telehealth advocates came out in support of the decision.
These flexibilities…